Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited Stage”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT05418673
What this trial is testing

Assess if BIIB122 Tablets Are Safe and Can Slow Worsening of Early-Stage Parkinson's Disease in Participants With Specific LRRK2 Genetic Variants Between the Ages of 30 and 80 Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale

Who this might be right for
Parkinson Disease
Biogen 7
Early research (Phase 1)Looking for participantsNCT06430541
What this trial is testing

Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence

Who this might be right for
Breast CancerOvarian Cancer
University of Colorado, Denver 20
Not applicableStudy completedNCT03925103
What this trial is testing

Assessment of Ergonomics in 3D vs 2D Thoracoscopic Lobectomy

Who this might be right for
Early Stage Non-small-cell Lung Cancer (Stage 1-2)
University of Rome Tor Vergata 70
Not applicableUnknownNCT03870802
What this trial is testing

MACSSI (MAstectomie Cellules Souches Surveillance Immunitaire)

Who this might be right for
Breast Cancer
Centre Leon Berard 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT02592083
What this trial is testing

Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors

Who this might be right for
Early-Stage Breast CarcinomaHormone Receptor Positive Tumor
Thomas Hatschek 10
Testing effectiveness (Phase 2)Study completedNCT00470054
What this trial is testing

Dasatinib in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung CancerLimited Stage Small Cell Lung CancerRecurrent Small Cell Lung Cancer
National Cancer Institute (NCI) 44
Not applicableEnded earlyNCT04376502
What this trial is testing

Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma.

Who this might be right for
Metastatic Carcinoma
Baptist Health South Florida 12
Not applicableNot Yet RecruitingNCT07597642
What this trial is testing

ON-treatment Single-cell Analysis for the Identification of Early Tumor Response Biomarkers on Prospective Collected Serial Tumor Biopsies in Triple Negative Breast Cancer Patient During Standard Neoadjuvant Chemo-immunotherapy

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
IRCCS San Raffaele 55
Not applicableUnknownNCT03821454
What this trial is testing

Capecitabine in the Treatment of Breast Cancer With Low-hormone Receptor Expression After Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
Zhejiang Cancer Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00436566
What this trial is testing

Doxorubicin and Cyclophosphamide Followed By Trastuzumab, Paclitaxel, and Lapatinib in Treating Patients With Early-Stage HER2-Positive Breast Cancer That Has Been Removed By Surgery

Who this might be right for
Breast CancerCardiac Toxicity
Mayo Clinic 122
Testing effectiveness (Phase 2)Study completedNCT07182305
What this trial is testing

Treatment Trial of Alveolar Echinococcosis

Who this might be right for
Alveolar Echinococcosis
Ministry of Health, Kyrgyzstan 194
Not applicableNot Yet RecruitingNCT07097103
What this trial is testing

Parkinson's Research In Metagenomic Early Stage Biomarkers

Who this might be right for
Parkinson's Disease (PD)
IRCCS San Raffaele Roma 80
Testing effectiveness (Phase 2)Study completedNCT00306566
What this trial is testing

Safety and Immunogenicity of a Melan-A VLP Vaccine in Early Stage Melanoma Patients

Who this might be right for
Malignant Melanoma
Cytos Biotechnology AG
Not applicableStudy completedNCT03288922
What this trial is testing

Protein-bound Toxin Removal Between Limited Blood Flow Super High-flux Online HDF and High-Efficiency Online HDF

Who this might be right for
End-stage Renal DiseaseHemodialysis
Chulalongkorn University 10
Not applicableStudy completedNCT03911856
What this trial is testing

Unmasking Right Ventricular and Pulmonary Derangements With Exercise and Oxygen in Early Stage Cardiopulmonary Diseases

Who this might be right for
Cardiopulmonary Disease
Mayo Clinic 7
Not applicableUnknownNCT02933294
What this trial is testing

Uniportal Versus Triportal Thoracoscopic Lobectomy and Sublobectomy for Early Stage Lung Cancer

Who this might be right for
Lung Neoplasms
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 356
Testing effectiveness (Phase 2)Looking for participantsNCT05932680
What this trial is testing

Limited-duration Teclistamab

Who this might be right for
Myeloma Multiple
Abramson Cancer Center at Penn Medicine 75
Not applicableEnrolling By InvitationNCT06924788
What this trial is testing

Video-Conferenced Stress Management and Relaxation Training (VSMART) For Alabama Breast Cancer Survivors

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
University of Alabama at Birmingham 25
Not applicableStudy completedNCT00496249
What this trial is testing

The Effect of Radiation on Semen Quality and Fertility in Men With Prostate Cancer

Who this might be right for
Prostate Cancer
University Health Network, Toronto 19
Testing effectiveness (Phase 2)Study completedNCT00165243
What this trial is testing

Tangential Radiation Therapy Without Axillary Dissection in Breast Cancer

Who this might be right for
Early-Stage Breast Cancer
Dana-Farber Cancer Institute 100
Next Page